Jennifer A Wagman1, Ronald H Gray2, Jacquelyn C Campbell3, Marie Thoma4, Anthony Ndyanabo5, Joseph Ssekasanvu5, Fred Nalugoda5, Joseph Kagaayi5, Gertrude Nakigozi5, David Serwadda6, Heena Brahmbhatt4. 1. Division of Global Public Health, School of Medicine, University of California, San Diego, La Jolla, CA, USA. Electronic address: jwagman@ucsd.edu. 2. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 3. School of Nursing, Johns Hopkins University, Baltimore, MD, USA. 4. Department of Population, Family and Reproductive Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. 5. Rakai Health Sciences Program, Uganda Virus Research Institute, Entebbe, Uganda. 6. School of Public Health, New Mulago Hospital Complex, Makerere University, Kampala, Uganda.
Abstract
BACKGROUND:Intimate partner violence (IPV) is associated with HIV infection. We aimed to assess whether provision of a combination of IPV prevention and HIV services would reduce IPV and HIV incidence in individuals enrolled in the Rakai Community Cohort Study (RCCS), Rakai, Uganda. METHODS: We used pre-existing clusters of communities randomised as part of a previous family planning trial in this cohort. Four intervention group clusters from the previous trial were provided standard of care HIV services plus a community-level mobilisation intervention to change attitudes, social norms, and behaviours related to IPV, and a screening and brief intervention to promote safe HIV disclosure and risk reduction in women seeking HIV counselling and testing services (the Safe Homes and Respect for Everyone [SHARE] Project). Seven control group clusters (including two intervention groups from the original trial) received only standard of care HIV services. Investigators for the RCCS did a baseline survey between February, 2005, and June, 2006, and two follow-up surveys between August, 2006, and April, 2008, and June, 2008, and December, 2009. Our primary endpoints were self-reported experience and perpetration of past yearIPV (emotional, physical, and sexual) and laboratory-based diagnosis of HIV incidence in the study population. We used Poisson multivariable regression to estimate adjusted prevalence risk ratios (aPRR) of IPV, and adjusted incidence rate ratios (aIRR) of HIV acquisition. This study was registered with ClinicalTrials.gov, number NCT02050763. FINDINGS:Between Feb 15, 2005, and June 30, 2006, we enrolled 11 448 individuals aged 15-49 years. 5337 individuals (in four intervention clusters) were allocated into the SHARE plus HIV services group and 6111 individuals (in seven control clusters) were allocated into the HIV services only group. Compared with control groups, individuals in the SHARE intervention groups had fewer self-reports of past-year physical IPV (346 [16%] of 2127 responders in control groups vs 217 [12%] of 1812 responders in intervention groups; aPRR 0·79, 95% CI 0·67-0·92) and sexual IPV (261 [13%] of 2038 vs 167 [10%] of 1737; 0·80, 0·67-0·97). Incidence of emotional IPV did not differ (409 [20%] of 2039 vs 311 [18%] of 1737; 0·91, 0·79-1·04). SHARE had no effect on male-reported IPV perpetration. At follow-up 2 (after about 35 months) the intervention was associated with a reduction in HIV incidence (1·15 cases per 100 person-years in control vs 0·87 cases per 100 person-years in intervention group; aIRR 0·67, 95% CI 0·46-0·97, p=0·0362). INTERPRETATION: SHARE could reduce some forms of IPV towards women and overall HIV incidence, possibly through a reduction in forced sex and increased disclosure of HIV results. Findings from this study should inform future work toward HIV prevention, treatment, and care, and SHARE's ecological approach could be adopted, at least partly, as a standard of care for other HIV programmes in sub-Saharan Africa. FUNDING: Bill & Melinda Gates Foundation, US National Institutes of Health, WHO, President's Emergency Plan for AIDS Relief, Fogarty International Center.
RCT Entities:
BACKGROUND: Intimate partner violence (IPV) is associated with HIV infection. We aimed to assess whether provision of a combination of IPV prevention and HIV services would reduce IPV and HIV incidence in individuals enrolled in the Rakai Community Cohort Study (RCCS), Rakai, Uganda. METHODS: We used pre-existing clusters of communities randomised as part of a previous family planning trial in this cohort. Four intervention group clusters from the previous trial were provided standard of care HIV services plus a community-level mobilisation intervention to change attitudes, social norms, and behaviours related to IPV, and a screening and brief intervention to promote safe HIV disclosure and risk reduction in women seeking HIV counselling and testing services (the Safe Homes and Respect for Everyone [SHARE] Project). Seven control group clusters (including two intervention groups from the original trial) received only standard of care HIV services. Investigators for the RCCS did a baseline survey between February, 2005, and June, 2006, and two follow-up surveys between August, 2006, and April, 2008, and June, 2008, and December, 2009. Our primary endpoints were self-reported experience and perpetration of past year IPV (emotional, physical, and sexual) and laboratory-based diagnosis of HIV incidence in the study population. We used Poisson multivariable regression to estimate adjusted prevalence risk ratios (aPRR) of IPV, and adjusted incidence rate ratios (aIRR) of HIV acquisition. This study was registered with ClinicalTrials.gov, number NCT02050763. FINDINGS: Between Feb 15, 2005, and June 30, 2006, we enrolled 11 448 individuals aged 15-49 years. 5337 individuals (in four intervention clusters) were allocated into the SHARE plus HIV services group and 6111 individuals (in seven control clusters) were allocated into the HIV services only group. Compared with control groups, individuals in the SHARE intervention groups had fewer self-reports of past-year physical IPV (346 [16%] of 2127 responders in control groups vs 217 [12%] of 1812 responders in intervention groups; aPRR 0·79, 95% CI 0·67-0·92) and sexual IPV (261 [13%] of 2038 vs 167 [10%] of 1737; 0·80, 0·67-0·97). Incidence of emotional IPV did not differ (409 [20%] of 2039 vs 311 [18%] of 1737; 0·91, 0·79-1·04). SHARE had no effect on male-reported IPV perpetration. At follow-up 2 (after about 35 months) the intervention was associated with a reduction in HIV incidence (1·15 cases per 100 person-years in control vs 0·87 cases per 100 person-years in intervention group; aIRR 0·67, 95% CI 0·46-0·97, p=0·0362). INTERPRETATION: SHARE could reduce some forms of IPV towards women and overall HIV incidence, possibly through a reduction in forced sex and increased disclosure of HIV results. Findings from this study should inform future work toward HIV prevention, treatment, and care, and SHARE's ecological approach could be adopted, at least partly, as a standard of care for other HIV programmes in sub-Saharan Africa. FUNDING: Bill & Melinda Gates Foundation, US National Institutes of Health, WHO, President's Emergency Plan for AIDS Relief, Fogarty International Center.
Authors: Tom Lutalo; Godfrey Kigozi; Edward Kimera; David Serwadda; Maria J Wawer; Laurie Schwab Zabin; Ronald H Gray Journal: Stud Fam Plann Date: 2010-03
Authors: Jennifer A Wagman; Fredinah Namatovu; Fred Nalugoda; Deus Kiwanuka; Gertrude Nakigozi; Ron Gray; Maria J Wawer; David Serwadda Journal: Violence Against Women Date: 2012-12
Authors: Ron Gray; Godfrey Kigozi; Xiangrong Kong; Victor Ssempiija; Frederick Makumbi; Stephen Wattya; David Serwadda; Fred Nalugoda; Nelson K Sewenkambo; Maria J Wawer Journal: AIDS Date: 2012-03-13 Impact factor: 4.177
Authors: Xiangrong Kong; Anthony Ndyanabo; Fred Nalugoda; Godfrey Kigozi; Joseph Ssekasanvu; Tom Lutalo; David Serwadda; Maria Wawer; Ronald Gray Journal: AIDS Date: 2013-02-20 Impact factor: 4.177
Authors: Jacquelyn C Campbell; Marguerite B Lucea; Jamila K Stockman; Jessica E Draughon Journal: Am J Reprod Immunol Date: 2012-10-16 Impact factor: 3.886
Authors: Jennifer Wagman; Joy Noel Baumgartner; Cindy Waszak Geary; Neema Nakyanjo; William George Ddaaki; David Serwadda; Ron Gray; Fred Kakaire Nalugoda; Maria J Wawer Journal: J Interpers Violence Date: 2008-12-24
Authors: Fiona G Kouyoumdjian; Liviana M Calzavara; Susan J Bondy; Patricia O'Campo; David Serwadda; Fred Nalugoda; Joseph Kagaayi; Godfrey Kigozi; Maria Wawer; Ron Gray Journal: AIDS Date: 2013-05-15 Impact factor: 4.177
Authors: Jennifer A Wagman; Ronald H Gray; Neema Nakyanjo; Katherine A McClendon; Erika Bonnevie; Fredinah Namatovu; Grace Kigozi; Joseph Kagaayi; Maria J Wawer; Fred Nalugoda Journal: Eval Program Plann Date: 2017-12-24
Authors: Amy A Conroy; Alexander C Tsai; Gina M Clark; Yap Boum; Abigail M Hatcher; Annet Kawuma; Peter W Hunt; Jeffrey N Martin; David R Bangsberg; Sheri D Weiser Journal: AIDS Behav Date: 2016-09
Authors: Anna M Leddy; Sheri A Lippman; Torsten B Neilands; Rhian Twine; Jennifer Ahern; Francesc Xavier Gómez-Olivé; Stephanie M DeLong; Catherine MacPhail; Kathleen Kahn; Audrey E Pettifor Journal: J Epidemiol Community Health Date: 2018-11-19 Impact factor: 3.710
Authors: Michael Baiocchi; Benjamin Omondi; Nickson Langat; Derek B Boothroyd; Jake Sinclair; Lee Pavia; Munyae Mulinge; Oscar Githua; Neville H Golden; Clea Sarnquist Journal: Prev Sci Date: 2017-10